Abu dhabi: H.H. Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, has met with Michel Demar©, Chair of AstraZeneca, a leader in the biopharmaceutical industry. The meeting included members of AstraZeneca's Board of Directors and focused on discussing opportunities to strengthen their strategic partnership and explore further collaboration in the pharmaceutical and biotechnology sectors.

According to Emirates News Agency, both parties emphasized the importance of supporting innovation in the healthcare sector. They discussed investment in clinical research and biotechnology as a means to reinforce their joint commitment to developing innovative solutions that advance research and development in health sciences. This collaboration aims to enhance the quality of life locally, regionally, and globally.

The meeting also saw the presence of key figures from the Abu Dhabi leadership, including Mansour Ibrahim Al Mansouri, Chairman of the Department of Health - Abu Dhabi; Ahmed Jasem Al Zaabi, Chairman of the Abu Dhabi Department of Economic Development; and Saif Saeed Ghobash, Secretary-General of the Abu Dhabi Executive Council and Chairman of the Office of the Crown Prince.